[1]Kategava LS,Changkakoty B,Biechele T,et al.Bili inhibits Wnt/beta-catenin signaling by regulating the recruitment of axin to LRP6[J].PLoS One,2009,4(7):e6129.
[2]Chishti AH, Kim AC, Marfatia SM, et al. The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane[J]. Trends Biochem Sci, 1998, 23, 281-282.
[3]Frame MC, Patel H, Serrels B,et al.The FERM domain: organizing the structure and function of FAK[J]. Nat Rev Mol Cell Biol, 2010, 11(11): 802-814.
[4]Zhan J, Zhu X, Guo Y, et al. Opposite role of Kindlin-1 and Kindlin-2 in lung cancers[J]. PLoS One,2012,7(11):e50313.
[5]Haase D, Meister M, Muley T,et al. FRMD3, a novel putative tumour suppressor in NSCLC[J]. Oncogene,2007,26(30): 4464-4468.
[6]Hu J, Niu M, Li X,et al.FERM domain-containing protein FRMD5 regulates cll motility via binding to integrin beta5 subunit and ROCK1[J].FEBS Lett,2014,588(23):4348-4355.
[7]Wang T, Pei X, Zhan J, et al. FERM-containing protein FRMD5 is a p120-catenin interacting protein that regulates tumor progression[J]. FEBS Lett, 2012,586(19): 3044-3050.
[8]Galvan A, Falvella FS, Frullanti E, et al. Genome-wide association study in discordant sibships identifies multiple inherited susceptibility alleles linked to lung cancer[J]. Carcinogenesis, 2010,31(3): 462-465.
[9]Longobardi Iotti G, Di Rosa P, et al. Prep1 (pKnox1)-deficiency leads to spontaneous tumor development in mice and accelerates EmuMyc lymphomagenesis: a tumor suppressor role for Prep1[J]. Mol Oncol, 2010, 4(2): 126-134.
[10]Lim ST, Chen XL, Lim Y, et al. Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation[J]. Mol Cell,2008(1):29, 9-22.
[11]Hamaratoglu F, Willecke M, Kango-Singh M,et al. The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis[J]. Nat Cell Biol,2006,8(1): 27-36.
[12]Wang L, Deng W, Shi T, et al. URP2SF, a FERM and PH domain containing protein, regulates NF-kappaB and apoptosis[J]. Biochem Biophys Res Commun, 2008,368(4): 899-906.
[13]Jakel H, Weinl C, Hengst L, et al. Phosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle control[J]. Oncogene,2011,30(32): 3502-3512.
[14]Lim ST, Miller NL, Nam JO,et al. Pyk2 inhibition of p53 as an adaptive and intrinsic mechanism facilitating cell proliferation and survival[J]. J Biol Chem,2010,285(3): 1743-1753.
[15]Wang Z, Ma B, Li H, et al. Protein 4-1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC[J]. Oncotarget, 2016,(1): 509-523.
[16]Yang M, Chen X,Zhang ShW,et al, Research progress of biological function in integrin-interacting protein kindlin family[J].Acta Anatomica Sinica,2014,45(6):865-869. (in Chinese)
杨玫,陈曦,张水文,等,整合素相互作用蛋白Kindlin 家族的生物学功能研究进展[J].解剖学报,2014,45(6): 865-869.
[17]Hyduk SJ, Rullo J, Cano AP, et al.Talin-1 and kindlin-3 regulate alpha4beta1 integrin-mediated adhesion stabilization, but not G protein-coupled receptor-induced affinity upregulation[J]. J Immunol, 2011,187(8): 4360-4368.
[18]Pinon P, P?rssinen J, Vazquez P, et al. Talin-bound NPLY motif recruits integrin-signaling adapters to regulate cell spreading and mechanosensing[J]. J Cell Biol, 2014, 205(2): 265-281.
[19]Melis M,Cau M,Corraine S, et al.Cerebral cavernous malformations and unilateral moyamoya in a patient with a new mutation in the KRIT-1/CCM1 gene[J].Cerebrovasc Dis, 2014, 38(4):311-312.
[20]Han M, Nagele E, DeMarshall C,et al.Diagnosis of Parkinson’s disease based on disease-specific autoantibody profiles in human sera[J]. PLoS One, 2012, 7(2): e32383.
[21]Santiago JA, Potashkin JA.Current challenges towards the development of a blood test for Parkinson’s,disease[J]. Diagnostics(Basel),2014,4(4) :153-164.
|